Patent · US Active

Oral dosage forms including an antiplatelet agent and an acid inhibitor

US9504678B2 · kind B2 · utility

1Cited by
13References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2007
Grant dateNov 29, 2016
Priority date
Expiry dateDec 28, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides oral dosage forms comprising an antiplatelet agent and an acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and an acid inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.